Testosterone and Related Studies Looking for Patients

[Nelson Vergel]

[TABLE="class: data_table margin-top, width: 934"]
[TR="class: title-row, bgcolor: #EEEEEE"]
[TH]Rank[/TH]
[TH]Status[/TH]
[TH]Study[/TH]
[/TR]
[TR]
[TD="align: center"]1[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Anabolic and Inflammatory Responses to Short-Term Testosterone Administration in Older Men[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Sarcopenia[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Testosterone injection; Drug: Testosterone gel[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]2[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Testosterone for Penile Rehab After Radical Prostatectomy[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Conditions:[/TH]
[TD]Low Testosterone Levels; Erectile Dysfunction[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Testim® + Viagra®; Drug: Placebo Testim® + Viagra®[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]3[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Hypogonadism[/TD]
[/TR]
[TR]
[TH="align: right"]Intervention:[/TH]
[TD]Drug: Testosterone enanthate auto-injector[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]4[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Conditions:[/TH]
[TD]Testosterone; Trauma; Brain Injury[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Androgel (Testosterone Gel); Drug: Androgel Placebo[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]5[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Diagnostic Relevance of Salivary Testosterone Concentrations in Doping Control.[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Conditions:[/TH]
[TD]Circadian; Exercise; Testosterone[/TD]
[/TR]
[TR]
[TH="align: right"]Intervention:[/TH]
[TD]Drug: Testosterone supplementation[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]6[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Effect of Testosterone Treatment on Embryo Quality[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Conditions:[/TH]
[TD]Primary Ovarian Insufficiency; Female Infertility Due to Diminished Ovarian Reserve[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Testosterone cream (0.5mg per gram); Dietary Supplement: DHEA; Drug: Placebo[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]7[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With Hypogonadism[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Conditions:[/TH]
[TD]Type 2 Diabetes; Hypogonadism[/TD]
[/TR]
[TR]
[TH="align: right"]Intervention:[/TH]
[TD]Drug: Testosterone[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]8[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Metabolomics During Testosterone Therapy[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Testosterone Deficiency[/TD]
[/TR]
[TR]
[TH="align: right"]Intervention:[/TH]
[TD]Drug: Testosterone Therapy[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]9[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Peyronie's Disease[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Vitamin D2; Drug: Vitamin E; Drug: Testosterone Pellets[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]10[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Testosterone and Pain Sensitivity[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Conditions:[/TH]
[TD]Low Testosterone; Hypogonadism; Pain[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Testosterone Gel; Drug: Placebo Gel[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]11[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Benefit of the Treatment With Testosterone in Chronic Heart Failure Testosterone Deficiency Subjects[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Heart Failure[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Testosterone undecanoate; Drug: Saline isotonic solution[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]12[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Exercise Training and Testosterone Replacement in Heart Failure Patients[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Heart Failure[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Testosterone replacement; Other: Exercise training[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]13[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Testosterone Replacement in Metabolic Syndrome and Inflammation[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Conditions:[/TH]
[TD]Hypogonadism; Metabolic Syndrome; Obesity; Erectile Dysfunction[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Testosterone; Drug: Placebo[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]14[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]The Effects of Long Term Cyclic Testosterone Administration on Muscle Function and Bone in Older Men[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Sarcopenia[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Testosterone enanthate; Drug: Placebo[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]15[/TD]
[TD="align: center"]Not yet recruiting[/TD]
[TD]Testosterone Undecanoate and Quality of Life of Men and Spouses[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Hypogonadism[/TD]
[/TR]
[TR]
[TH="align: right"]Intervention:[/TH]
[TD]Drug: testosterone undecanoate[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]16[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin, Which Regulates Blood Sugar Levels[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Conditions:[/TH]
[TD]Insulin Resistance; Type 2 Diabetes Mellitus; Obesity; Androgen Deficiency; Metabolic Disease[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Acyline; Drug: Testosterone 1.62% gel; Drug: Letrozole; Drug: Placebo gel (for Testosterone 1.62% gel); Drug: Placebo pill (for Letrozole)[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]17[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistant (The RESTORE Study)[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Prostate Cancer[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Testosterone cypionate; Drug: Testosterone Enanthate; Drug: Abiraterone acetate; Drug: Enzalutamide[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]18[/TD]
[TD="align: center"]Not yet recruiting[/TD]
[TD]A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Adult Male Hypogonadism[/TD]
[/TR]
[TR]
[TH="align: right"]Intervention:[/TH]
[TD]Drug: Testosterone Gel (FE 999303)[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]19[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Transdermal Testosterone Pretreatment in Poor Responders Undergoing IVF[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Subfertility[/TD]
[/TR]
[TR]
[TH="align: right"]Intervention:[/TH]
[TD]Drug: Testosterone[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]20[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Testosterone Replacement in Non-alcoholic Steatohepatitis (TEREPINS)[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Conditions:[/TH]
[TD]Nonalcoholic Steatohepatitis; Hypogonadism[/TD]
[/TR]
[TR]
[TH="align: right"]Intervention:[/TH]
[TD]Drug: testosterone undecanoate[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[/TABLE]

 

[Nelson Vergel]

[TABLE="class: data_table margin-top, width: 934"]
[TR="class: title-row, bgcolor: #EEEEEE"]
[TH]Rank[/TH]
[TH]Status[/TH]
[TH]Study[/TH]
[/TR]
[TR]
[TD="align: center"]21[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Testosterone Antidepressant Augmentation in Women[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Depression[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Testosterone; Drug: Placebo[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]22[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Clomid in Men With Low Testosterone With and Without Prior Treatment[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Hypogonadism, Male[/TD]
[/TR]
[TR]
[TH="align: right"]Intervention:[/TH]
[TD]Drug: Clomiphene[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]23[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Testosterone Replacement in Men With Diabetes and Obesity[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Hypogonadism[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: testosterone; Drug: placebo[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]24[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Testosterone and Alendronate in Hypogonadal Men[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Conditions:[/TH]
[TD]Hypogonadism; Osteopenia; Osteoporosis[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Testosterone; Drug: Alendronate; Drug: Placebo Alendronate; Drug: Placebo Testosterone[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]25[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Testosterone Administration and ACL Reconstruction in Men[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Conditions:[/TH]
[TD]Muscle Atrophy; ACL Reconstruction; Trauma; Osteoarthritis[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Testosterone; Drug: Saline[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]26[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Comparison of Salivary and Serum Free Testosterone in Normal and Hypogonadal Men[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Known Androgen Deficiency[/TD]
[/TR]
[TR]
[TH="align: right"]Intervention:[/TH]
[TD][/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]27[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Resistance Training and Testosterone After Spinal Cord Injury[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Spinal Cord Injury[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Procedure: Resistance Training and Testosterone Patches; Drug: Testosterone Patches[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]28[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]CYP19A1 Gene and Pharmacogenetics of Response to Testosterone Therapy[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Hypogonadism[/TD]
[/TR]
[TR]
[TH="align: right"]Intervention:[/TH]
[TD]Drug: Testosterone Cypionate[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]29[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Study of Psychological and Motor Effects of Testosterone in Adolescents With XXY/Klinefelter Syndrome[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Conditions:[/TH]
[TD]Klinefelter Syndrome; XXY Syndrome[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Testosterone gel 1%; Drug: Placebo gel[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]30[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Testosterone for Treating Cachexia in Patients With Advanced or Recurrent Cervical Cancer[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Conditions:[/TH]
[TD]Cachexia; Cervical Cancer[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Standard of Care Chemotherapy and/or Radiation plus Placebo (Saline) Testosterone; Drug: Arm II: Standard of Care Chemotherapy and/or Radiation plus Testosterone Enanthate[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]31[/TD]
[TD="align: center"]Not yet recruiting[/TD]
[TD]Study of the Effect of Testosterone and Estradiol on NP Responses to Acute and Chronic Salt Loading[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Hypertension[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: leuprolide acetate; Drug: Anastrozole[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]32[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Dose-Response of Gonadal Steroids and Bone Turnover in Men[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Healthy Volunteers[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Testosterone; Drug: Anastrazole; Drug: Goserelin acetate[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]33[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Conditions:[/TH]
[TD]Arthralgia; Breast Cancer; Hot Flashes; Musculoskeletal Complications; Sexual Dysfunction[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: therapeutic testosterone; Other: placebo[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]34[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Testosterone Replacement for Male Opioid Agonist Maintained Patients[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Conditions:[/TH]
[TD]Chronic Pain; Opioid Addiction; Symptomatic Hypogonadism[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Testosterone replacement; Other: Waitlist control[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]35[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Testosterone and Weight Loss[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Obesity in Men[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Testosterone; Drug: placebo[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]36[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Optimizing Protein Intake in Older Americans With Mobility Limitations[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Mobility Limitation[/TD]
[/TR]
[TR]
[TH="align: right"]Intervention:[/TH]
[TD]Drug: Testosterone enanthate[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]37[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Female Orgasmic Disorder[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Placebo; Drug: Low dose TBS-2; Drug: Medium dose TBS-2; Drug: High dose TBS-2[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]38[/TD]
[TD="align: center"]Not yet recruiting[/TD]
[TD]ITT-5 Mechanisms of Spermatogenesis[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Gonadotropin Deficiency[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Testosterone 1% Gel; Drug: Acyline; Drug: Dutasteride; Drug: Ketoconazole; Drug: HCG; Drug: placebo dutasteride; Drug: placebo ketoconazole[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]39[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Testogel® (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Hypogonadism[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Testogel 1%; Drug: Placebo[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]40[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication Administration[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Conditions:[/TH]
[TD]Hypogonadism; Opioid-Related Disorders; Male Infertility[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Clomiphene citrate; Drug: Placebo[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[/TABLE]

 

[Nelson Vergel]

[TABLE="class: data_table margin-top, width: 934"]
[TR="class: title-row, bgcolor: #EEEEEE"]
[TH]Rank[/TH]
[TH]Status[/TH]
[TH]Study[/TH]
[/TR]
[TR]
[TD="align: center"]41[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]A Study to Evaluate a Skeletal-muscle Microbiopsy Technique With Dynamic Proteomic Measurement in Healthy Male Volunteers[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Cachexia[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Deuterated Water; Drug: Testosterone enanthate; Drug: Placebo to match testosterone enanthate[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]42[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Effect of Androgel on Atherogenesis in Type 2 Diabetic Males With Hypogonadotrophic Hypogonadism[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Type 2 Diabetic Male With Hypogonadotrophic Hypogonadism[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: androgel; Drug: placebo[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]43[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Hormonal Factors in the Treatment of Anorexia Nervosa[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Conditions:[/TH]
[TD]Anorexia Nervosa; Eating Disorder; Anxiety; Depression[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Testosterone; Drug: Placebo[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]44[/TD]
[TD="align: center"]Recruiting[/TD]
[TD][18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Prostate Cancer[/TD]
[/TR]
[TR]
[TH="align: right"]Intervention:[/TH]
[TD]Drug: [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]45[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Constitutional Delay of Growth and Puberty: Towards Evidence-based Treatment[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Constitutional Delay of Growth and Puberty[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Testosterone; Drug: Letrozole[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]46[/TD]
[TD="align: center"]Not yet recruiting[/TD]
[TD]Androgen Regulation of Priapism in Sickle Cell Disease[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Conditions:[/TH]
[TD]Priapism; Sickle Cell Disease[/TD]
[/TR]
[TR]
[TH="align: right"]Intervention:[/TH]
[TD]Drug: Transdermal Androgel[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]47[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Sleep-wake Changes of Luteinizing Hormone Frequency in Pubertal Girls With and Without High Testosterone[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Hyperandrogenism[/TD]
[/TR]
[TR]
[TH="align: right"]Intervention:[/TH]
[TD][/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]48[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Androgen for Leydig Cell Proliferation[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Conditions:[/TH]
[TD]Klinefelter Syndrome; Hypergonadotropic Hypogonadism; Hypergonadotropic Azospermia; Hypergonadotropic Cryptozoospermia[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Testosterone undecanoate; Drug: Castor Oil[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]49[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Effect of High Testosterone on Sleep-associated Slowing of Follicular Luteinizing Hormone (LH) Frequency in Polycystic Ovary Syndrome[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Polycystic Ovary Syndrome[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Flutamide; Drug: Placebo[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]50[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Feasibility Study of Post-hospitalization Interventions to Improve Physical Function in Older Adults[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Aging[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Placebo; Dietary Supplement: Nutritional Supplement; Behavioral: In-home exercise; Drug: Testosterone[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]51[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Vitamin D Treatment and Hypogonadism in Men[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Hypogonadism[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Vitamin D supplementation in hypogonadal men; Drug: Vitamin D supplementation in eugonadal men; Drug: Placebo hypogonadal; Drug: Placebo eugonadal[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]52[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Long Acting LHRH Versus Short Acting LHRH in the Treatment of Prostate Cancer[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Prostate Cancer[/TD]
[/TR]
[TR]
[TH="align: right"]Intervention:[/TH]
[TD]Drug: luteinizing hormone-releasing hormone (LHRH) short acting or long acting[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]53[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Prostate Cancer[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: GTx-758 125 mg; Drug: GTx-758 250 mg[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]54[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Treatment of Prostate Cancer With Firmagon®[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Prostate Cancer[/TD]
[/TR]
[TR]
[TH="align: right"]Intervention:[/TH]
[TD]Drug: Degarelix[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]55[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Impact of Estradiol Addback[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Normal Healthy Volunteers[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Degarelix; Drug: Testosterone; Drug: Anastrozole; Drug: Estrogen patch[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]56[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Burns[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Procedure: Stable Isotope Infusion Study; Procedure: Collection of blood and tissues; Procedure: Radiology testing: Dual-energy X-ray absorptiometry (DEXA), ultrasound, MRI; Drug: Humatrope; Drug: Ketoconazole; Drug: Oxandrolone; Drug: Propranolol; Drug: Oxandrolone and propranolol combined; Drug: Humatrope and propranolol combined; Drug: Placebo; Behavioral: Exercise--Hospital supervised intensive exercise program; Behavioral: Home exercise program[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]57[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Degarelix Before Radical Prostatectomy[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Prostate Cancer[/TD]
[/TR]
[TR]
[TH="align: right"]Intervention:[/TH]
[TD]Drug: 240mg degarelix s.c. injection[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]58[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS)[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]PCOS[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: Dexamethasone; Drug: recombinant human chorionic gonadotropin (r-hCG)[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]59[/TD]
[TD="align: center"]Not yet recruiting[/TD]
[TD]Ovulation Induction in Women With Clomiphene Citrate Resistant PCOS[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Conditions:[/TH]
[TD]Polycystic Ovary Syndrome; Infertility[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: induction of ovulation using letrozole-pioglitazone-metformin; Drug: induction of ovulation using clomiphene citrate-pioglitazone-metformin; Radiation: transvaginal ultrasound; Other: body mass index (BMI) calculation; Other: day 3: follicle stimulating hormone (FSH), luteinizing hormone (LH), thyroid stimulating hormone (TSH), total testosterone; Other: pretreatment blood urea and serum creatinine; Other: serum estradiol (E2) on day 12; Other: serum progesterone on day 21; Other: blood urea and serum creatinine every month[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[TR]
[TD="align: center"]60[/TD]
[TD="align: center"]Recruiting[/TD]
[TD]The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With Schizophrenia[TABLE="class: data_table body3"]
[TR]
[TH="align: right"]Condition:[/TH]
[TD]Schizophrenia[/TD]
[/TR]
[TR]
[TH="align: right"]Interventions:[/TH]
[TD]Drug: LY500307 25mg; Drug: LY500307 75mg; Drug: Placebo[/TD]
[/TR]
[/TABLE]
[/TD]
[/TR]
[/TABLE]